Showing results (491-500 of 520) with videos related to
Sort By:
Pageof 52
Molecular Medicine (Cambridge, Mass.)|July 23, 2016
Annexin A5 increases survival in murine sepsis model by inhibiting HMGB1-mediated pro-inflammation and coagulationJung Hwa Park, Jong-Hwa Jang, Eun Jung Choi, et al.Drug Delivery and Translational Research|May 13, 2014
Intraperitoneal delivery of paclitaxel by poly(ether-anhydride) microspheres effectively suppresses tumor growth in a murine metastatic ovarian cancer modelMing Yang, Tao Yu, Joseph Wood, et al.Immunology Letters|July 18, 2006
Enhancement of dendritic cell-based vaccine potency by targeting antigen to endosomal/lysosomal compartmentsTae Heung Kang, Jin Hyup Lee, Hyun Cheol Bae, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 5, 2013
Enhanced cancer radiotherapy through immunosuppressive stromal cell destruction in tumorsChao-Yi Wu, Li-Hua Yang, Huang-Yu Yang, et al.Human Pathology|April 1, 1996
The WAF1-mediated p53 growth-suppressor pathway is intact in the coronary arteries of heart transplant recipientsI O Baas, J A Offerhaus, W S El-Deiry, et al.Cancer|June 15, 2007
Generation and characterization of an ascitogenic mesothelin-expressing tumor modelWen-Fang Cheng, Chien-Fu Hung, Chee-Yin Chai, et al.Journal of Biomedical Science|October 8, 2024
Molecular targets and strategies in the development of nucleic acid cancer vaccines: from shared to personalized antigensWei-Yu Chi, Yingying Hu, Hsin-Che Huang, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 5, 2014
Toll-like receptor agonist imiquimod facilitates antigen-specific CD8+ T-cell accumulation in the genital tract leading to tumor control through IFNγRuey-Shyang Soong, Liwen Song, Janson Trieu, et al.The Journal of Clinical Investigation|November 2, 2023
In situ vaccination via tissue-targeted cDC1 expansion enhances the immunogenicity of chemoradiation and immunotherapyBrandon Lam, Yu Jui Kung, John Lin, et al.Clinical Pharmacology and Therapeutics|November 21, 2008
Assessment of the impact of renal impairment on systemic exposure of new molecular entities: evaluation of recent new drug applicationsY Zhang, L Zhang, S Abraham, et al.Pageof 52